About Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Theravance Biopharma
2
Clinical Trials at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre
During the past decade, Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants
2014-08-19
2026-09-29
Active, not recruiting
303
Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
2019-02-22
2021-11-10
Terminated
203
Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
2019-09-19
2021-11-12
Terminated
110
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
2020-08-24
2027-12-30
Active, not recruiting
800
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre
According to Clinical.Site data, the most researched conditions in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre" are
"Symptomatic Neurogenic Orthostatic Hypotension" (2 trials), "MSA" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Parkinson's Disease (PD)" (1 trials). Many other conditions were trialed in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre" in a lesser frequency.
Clinical Trials Intervention Types at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre
Most popular intervention types in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "ampreloxetine" (2 trials), "Alectinib" (1 trials), "Atezolizumab" (1 trials), "Crizotinib" (1 trials) and "Durvalumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre
The vast majority of trials in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre" are
4 trials for "All" genders.
Clinical Trials Status at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre
Currently, there are NaN active trials in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".